Day: March 9, 2021

VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) — Nanotech Security Corp. (TSXV: NTS) (OTCQX: NTSFF) (“Nanotech” or the “Company”), a leader in the development of secure and visually memorable nano-optic security features used in the government and banknote and brand protection markets, announces the launch of LiveOptik™ PROTECT security foil – a security foil designed specifically for the brand protection industry.LiveOptik PROTECT foil features a seamless, uniquely secure, photorealistic lock design that engages consumers while protecting the brand. The security foil has been designed with input from channel partners and is offered as an in-stock wallpaper design in a bulk roll format. Channel partners can easily convert the foils into various finished offerings and market them directly to their customer base. Custom...

SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) — Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that the first patient has been treated in its Phase 2a trial of MET642, a potent, sustained, non-bile acid farnesoid x-receptor (FXR) agonist, for the treatment of patients with non-alcoholic steatohepatitis (NASH).“NASH is a devastating disease, for which an optimized FXR agonist could play a foundational role in the treatment paradigm,” said Hubert C. Chen, M.D., chief medical officer of Metacrine. “MET642 has demonstrated an encouraging profile – including sustained pharmacodynamic effects without pruritus or low-density lipoprotein cholesterol increase – after 14...

TEL AVIV, Israel, March 09, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results for the fourth quarter and year ended December 31, 2020.Fourth Quarter 2020 and recent highlights:Announced the closing of an upsized underwritten public offering of $20.7 million.Announced the addition of renowned interventional cardiologist Gary Roubin, M.D., Ph.D., to the Board of Directors.Announced the appointment of leading interventional cardiologist Chris Metzger, M.D., system chair of clinical research at Ballad Health System in Eastern Tennessee as the principal investigator for its planned FDA registration trial for CGuard EPS.Secured China-based...

WAYNE, Pa., March 09, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH).In the United States alone, more than 42 million men are affected by BPH and approximately 12 million men are under a doctor’s care for the condition.1 This common, non-cancerous enlargement of the prostate occurs as men age and can interrupt sleep, cause urinary problems, and decrease quality of life.2“The UroLift System is a standard of care in my practice, and I confidently recommend it to appropriate patients who face the challenge of an enlarging prostate,” said Wayne Kuang, M.D.a “Many men are looking for alternatives to medications and major surgeries that have unwanted...

SUNNYVALE, Calif., March 09, 2021 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the leading provider of omnichannel customer engagement solutions, today announced it has been invited to participate in the following two investor conferences in March:Jefferies Enterprise Communications SummitFireside Chat: Wednesday, March 10th at 11:00 am PT1×1 meetings with investors on Wednesday, March 10th33rdAnnual Roth Conference1×1 meetings with investors on Tuesday, March 16theGain management will host virtual one-on-one meetings with institutional investors at these conferences. Meetings can be scheduled through the firms hosting the conferences or through MKR Investor Relations, eGain’s investor relations firm, at egan@mkr-group.com.To access a live webcast or replay of the fireside chat or formal presentation at these conferences,...

Highlights:Infill drilling continues to show good continuity in mineralisation with results grading up to 11 g/t Au over 7.2 metres and 136 g/t Au over 1 metre.Near-surface expansion drilling at New Beliveau returned 56.1 g/t Au over 1.1 metres, 8.2 g/t Au over 3 metres and 7.8 g/t Au over 3 metres.Near-surface expansion drilling at North Zone returned 96.6 g/t Au over 0.5 metre, 15.5 g/t Au over 1 metre and 1.5 g/t Au over 13 metres.All of these results will be included in the upcoming resource estimate expected in Q2-2021.TORONTO, March 09, 2021 (GLOBE NEWSWIRE) — Probe Metals Inc. (TSX-V: PRB) (OTCQB: PROBF) (“Probe” or the “Company”) is pleased to provide additional results from the 2020 drill program on its 100%-owned Val-d’Or East Pascalis property (the “Property”) located near Val-d’Or, Quebec. Results from seventy-one (71)...

Faits saillants :Le forage intercalaire continue de démontrer la bonne continuité de la minéralisation avec des résultats atteignant 11 g/t Au sur 7,2 mètres et 136 g/t Au sur 1 mètre.Le forage d’expansion à faible profondeur à New Béliveau livre des teneurs de 56,1 g/t Au sur 1,1 mètre, 8,2 g/t Au sur 3 mètres et 7,8 g/t Au sur 3 mètres.Le forage d’expansion à faible profondeur dans la zone Nord livre des teneurs de 96,6 g/t Au sur 0,5 mètre, 15,5 g/t Au sur 1 mètre et 1,5 g/t Au sur 13 mètres.Tous ces résultats seront intégrés à la prochaine estimation des ressources prévue au deuxième trimestre 2021.TORONTO, 09 mars 2021 (GLOBE NEWSWIRE) — Probe Metals Inc. (TSX-V : PRB) (OTCQB : PROBF) (« Probe » ou la « Société ») a le plaisir de publier de nouveaux résultats issus du programme de forage 2020 réalisé sur la propriété Pascalis...

Single-Dose Oxford–AstraZeneca COVID-19 Vaccine Followed by a 12-Week BoosterSAN CLEMENTE, CA, March 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Global WholeHealth Partners Corp (OTC: GWHP) continues the fight against COVID 19 by now offering the Vaccine for just $17.50 per vaccine.Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster.VOLUME 397, ISSUE 10277, P854-855, MARCH 06, 2021https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00528-6/fulltextCall (949) 757-4152 to place your order and get an allocation or email Global at Sales@gwhpcorp.com“Global understands that this is a war on COVID 19 and we are expanding our line of products to be able to fight,” states CEO Charles Storngo.“This is a wartime undertaking,” Biden said. “Today, I’m signing executive action to use the Defense Production...

SAN CLEMENTE, Calif., March 09, 2021 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that it has acquired Buena Vista Care Center, a 150-bed skilled nursing facility in the exclusive Southern California community of Santa Barbara. The facility will continue to be operated by California-based Covenant Care, Inc. under a long-term lease that CareTrust assumed in the off-market transaction.         “Not only is Buena Vista a special property, the icing on the cake is the opportunity to add an eighth facility to our existing relationship with Covenant Care,” said Mark Lamb, CareTrust’s Chief Investment Officer. “Covenant Care has established a long and admirable track record of providing excellent care to Santa Barbara’s residents and medical community,” he said. Mr. Lamb noted that Buena Vista Care Center is located...